Pharmacokinetic Study to Evaluate the Extent of Systemic Absorption of PEP005

• Status: Completed
• Trial end date: 2008-05-01
• Target enrollment: 0
• Participant gender: Male

Summary

The purpose of this study is to determine the extent of systemic absorption of PEP005 when applied topically for the treatment of actinic keratoses.

• Phase: Phase 1
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Peplin

Criteria

Inclusion Criteria:

1. Male patients at least 18 years of age.

2. A contiguous 100 cm2 treatment area containing at least 5 AK lesions, on the either the right or left extensor (dorsal aspect) forearm.

3. Written informed consent has been obtained.

4. Agreement from the patient to allow photographs of the selected AK treatment area to be taken and used as part of the study package.